Till a few years ago, it was a celebrated company; the first homegrown pharmaceutical major to become a multinational and its shares held a promising future. But since January, Ranbaxy......
The FDA has been tightening its monitoring of Indian pharma majors over compliance issues. Surprise plant inspections and import alerts have been frequent outcomes The US Food & Drug Administration......